← Open Payments lookup

KATIE GOOD: Open Payments

NPI 1093966178 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$431 in 14 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $115 · 2025 $431

Food & beverage: $262Education: $168
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP4$130
Janssen Biotech, Inc.2$122
Stemline Therapeutics Inc.2$40
Daiichi Sankyo Inc.2$38
Gilead Sciences, Inc.1$31
Incyte Corporation1$26
KYOWA KIRIN, INC.1$25
Novartis Pharmaceuticals Corporation1$19

Products named: ERLEADA, IMFINZI, LYNPARZA, Orserdu, Enhertu, Trodelvy, MONJUVI, POTELIGEO.

Industry payments across TX — which companies pay providers there.